Australia Market falls on Omicron fears

Image
Capital Market
Last Updated : Dec 20 2021 | 4:50 PM IST
The Australian share market finished session lower on Monday, 20 December 2021, following the broadly negative cues from Wall Street on Friday and drop in other Asian-pacific markets today, as the spread of the Omicron coronavirus variant continues to stoke worries over an economic slowdown worldwide.

At closing bell, the benchmark S&P/ASX200 was down 11.81 points, or 0.16%, to 7,292.16. The broader All Ordinaries index sank 24.01 points, or 0.31%, to 7,602.21.

The top performing stocks in this index were BLUESCOPE STEEL and VIVA ENERGY GROUP, up 4.1% and 3.7% respectively. The bottom performing stocks in this index were MAGELLAN FINANCIAL GROUP and CIMIC GROUP, down 32.9% and 13.4% respectively.

Total 8 of 11 sectors ended higher despite the decline in the S&P/ASX 200 Index. Health Care was the best performing sector, gaining +0.83%, while energy was the worst performing sector, falling 3.39%.

Market risk sentiments were largely subdued amid lingering concerns about the impact of the Omicron variant of the coronavirus, with the fast spreading variant now present in 89 countries. Domestically, New South Wales reported a record 2,501 new cases on Sunday, with no deaths. Victoria also reported 1,302 new cases, but no deaths.

Shares of energy companies were major drag on the market, due to declining crude oil prices. Santos declined by 4.8%, Ampol decreased by 1.5%, and Beach Energy fell by 4.3%.

Financials were lower, with ANZ Bank and Macquarie Group both down by 1.4%. National Australia Bank fell by 1%, but Commonwealth Bank closed 0.1% higher.

Shares of materials and resources were higher on the back of firmer iron ore prices. Fortescue rose 2.5% and BlueScope steel increased 4.1%. Rio Tinto welcomed its new chairman with a gain of 0.2%.

Shares of healthcare sector out-performed the market. thanks to a 0.6% gain in CSL and 2.9% rise in Sonic Healthcare. Ventilator maker Fisher & Paykel increased by 2.6%, and Clinuvel Pharmaceuticals gained 3.4%.

COMMODITY NEWS: Crude oil prices were lower in Asia trading hours amid concerns that continued spread of the omicron Covid variant likely to dent consumption demand, with the World Health Organization recently warning that the number of cases is doubling in 1.5 to 3 days in areas with community spread. International benchmark Brent crude futures fell by 3.3% to $71.13 per barrel. U.S. crude futures shed 3.71% to $68.23 per barrel.

CURRENCY NEWS: The Australian dollar was at $0.7091, off levels above $0.72 seen last week.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 20 2021 | 3:26 PM IST

Next Story